Physician profile
Bethany B Case
NPI 1508009382
$1,196.66
in general payments reported to CMS, 2019-2025
18 companies · $52.08 in 2025
The $52.08 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $221 · 2022: $125 · 2023: $140 · 2024: $658 · 2025: $52.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $850.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $189.05 | 2021-2024 | Otezla |
| Avanir Pharmaceuticals, INC. | $149.65 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $119.89 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $93.06 | 2024 | Breztri, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.78 | 2021 | |
| Lilly USA, LLC | $81.71 | 2023-2024 | Zepbound, Mounjaro |
| Inari Medical, INC. | $74.47 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $67.65 | 2024 | Rybelsus, Ozempic, Tresiba |
| Exact Sciences Corporation | $67.19 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $55.41 | 2024 | Arexvy, Trelegy Ellipta |
| Abbvie INC. | $50.00 | 2024-2025 | |
| Ironwood Pharmaceuticals, INC | $37.41 | 2023 | Linzess |
| Sumitomo Pharma America, INC. | $36.27 | 2024 | Gemtesa |
| Abbott Laboratories | $20.65 | 2024 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $19.97 | 2024 | Voquezna |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.16 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.96 | 2024 | Xifaxan, Trulance |
| Shield Therapeutics INC | $13.38 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Case listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.